跳至主要内容
临床试验/NCT00354692
NCT00354692已完成4 期

A Randomized Cross-over Pilot Study of the Effect of Sodium Ferric Gluconate Complex vs. Iron Sucrose on Proteinuria in Non-dialysis Chronic Kidney Disease Patients

Watson Pharmaceuticals0 个研究点目标入组 12 人开始时间: 2006年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
12
主要终点
Change in urine protein

研究概览

简要总结

This pilot study will compare the effects of sodium ferric gluconate complex and iron sucrose on urine concentrations of various chemicals including protein

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Moderate to severe anemia
  • Iron deficiency
  • Moderate to severe chronic kidney disease
  • Age ≥ 18 or greater and able to give informed consent

排除标准

  • Receiving dialysis
  • Known sensitivity to Sodium Ferric Gluconate Complex in Sucrose Injection, Iron sucrose USP, or any of their components
  • Clinically unstable
  • Indication of iron sufficiency

研究组 & 干预措施

Experimental

Experimental

干预措施: Sodium Ferric Gluconate and Iron sucrose (Drug)

结局指标

主要结局

Change in urine protein

时间窗: 180 minutes

次要结局

  • Change in various urine chemicals(180 minutes)

研究者

发起方
Watson Pharmaceuticals
申办方类型
Industry
责任方
Sponsor

相似试验